BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33407862)

  • 21. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
    Herson S; Hentati F; Rigolet A; Behin A; Romero NB; Leturcq F; Laforêt P; Maisonobe T; Amouri R; Haddad H; Audit M; Montus M; Masurier C; Gjata B; Georger C; Cheraï M; Carlier P; Hogrel JY; Herson A; Allenbach Y; Lemoine FM; Klatzmann D; Sweeney HL; Mulligan RC; Eymard B; Caizergues D; Voït T; Benveniste O
    Brain; 2012 Feb; 135(Pt 2):483-92. PubMed ID: 22240777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients.
    Xie Z; Hou Y; Yu M; Liu Y; Fan Y; Zhang W; Wang Z; Xiong H; Yuan Y
    Orphanet J Rare Dis; 2019 Feb; 14(1):43. PubMed ID: 30764848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
    Carotti M; Marsolier J; Soardi M; Bianchini E; Gomiero C; Fecchio C; Henriques SF; Betto R; Sacchetto R; Richard I; Sandonà D
    Hum Mol Genet; 2018 Mar; 27(6):969-984. PubMed ID: 29351619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing results.
    Giugliano T; Fanin M; Savarese M; Piluso G; Angelini C; Nigro V
    Neuromuscul Disord; 2016 Jun; 26(6):367-9. PubMed ID: 27108072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable high prevalence of limb-girdle muscular dystrophy type 2D in Taiwan.
    Liang WC; Chou PC; Hung CC; Su YN; Kan TM; Chen WZ; Hayashi YK; Nishino I; Jong YJ
    J Neurol Sci; 2016 Mar; 362():304-8. PubMed ID: 26944168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How a paternal uniparental isodisomy of chromosome 17 leads to autosomal recessive limb-girdle muscular dystrophy R3.
    Verebi C; Caumes R; Chantot-Bastaraud S; Deburgrave N; Orhant L; Vaucouleur N; Cuisset L; Bienvenu T; Leturcq F; Nectoux J
    Neuromuscul Disord; 2023 May; 33(5):367-370. PubMed ID: 36996638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
    Xu R; DeVries S; Camboni M; Martin PT
    Am J Pathol; 2009 Jul; 175(1):235-47. PubMed ID: 19498002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlations in alpha-sarcoglycanopathy: a systematic review.
    Carson L; Merrick D
    Ir J Med Sci; 2022 Dec; 191(6):2743-2750. PubMed ID: 35040091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Episodic myoglobinuria in a primary gamma-sarcoglycanopathy.
    Pena L; Kim K; Charrow J
    Neuromuscul Disord; 2010 May; 20(5):337-9. PubMed ID: 20356742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different outcome of sarcoglycan missense mutation between human and mouse.
    Henriques SF; Patissier C; Bourg N; Fecchio C; Sandona D; Marsolier J; Richard I
    PLoS One; 2018; 13(1):e0191274. PubMed ID: 29360879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-sarcoglycan gene mutations in Turkey.
    Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
    Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoglycanopathies.
    Kirschner J; Lochmüller H
    Handb Clin Neurol; 2011; 101():41-6. PubMed ID: 21496623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Founder mutation for α-sarcoglycan-LGMD2D in a Magdalen Islands Acadian cluster.
    Tétreault M; Srour M; Allyson J; Thiffault I; Loisel L; Robitaille Y; Bouchard JP; Brais B
    Can J Neurol Sci; 2011 Sep; 38(5):747-52. PubMed ID: 21856579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Classification of Canine Muscular Dystrophies and Identification of New Variants.
    Shelton GD; Minor KM; Friedenberg SG; Cullen JN; Guo LT; Mickelson JR
    Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo.
    Cassano M; Dellavalle A; Tedesco FS; Quattrocelli M; Crippa S; Ronzoni F; Salvade A; Berardi E; Torrente Y; Cossu G; Sampaolesi M
    Development; 2011 Oct; 138(20):4523-33. PubMed ID: 21903674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy.
    Ginjaar HB; van der Kooi AJ; Ceelie H; Kneppers AL; van Meegen M; Barth PG; Busch HF; Wokke JH; Anderson LV; Bönnemann CG; Jeanpierre M; Bolhuis PA; Moorman AF; de Visser M; Bakker E; Ommen GJ
    J Neurol; 2000 Jul; 247(7):524-9. PubMed ID: 10993494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T.
    Khadilkar SV; Singh RK; Hegde M; Urtizberea A; Love DR; Chong B
    Neurol India; 2009; 57(4):406-10. PubMed ID: 19770540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and immunohistochemical characterization of sarcoglycanopathies.
    Ferreira AF; Carvalho MS; Resende MB; Wakamatsu A; Reed UC; Marie SK
    Clinics (Sao Paulo); 2011; 66(10):1713-9. PubMed ID: 22012042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy.
    Alonso-Pérez J; González-Quereda L; Bello L; Guglieri M; Straub V; Gallano P; Semplicini C; Pegoraro E; Zangaro V; Nascimento A; Ortez C; Comi GP; Dam LT; De Visser M; van der Kooi AJ; Garrido C; Santos M; Schara U; Gangfuß A; Løkken N; Storgaard JH; Vissing J; Schoser B; Dekomien G; Udd B; Palmio J; D'Amico A; Politano L; Nigro V; Bruno C; Panicucci C; Sarkozy A; Abdel-Mannan O; Alonso-Jimenez A; Claeys KG; Gomez-Andrés D; Munell F; Costa-Comellas L; Haberlová J; Rohlenová M; Elke V; De Bleecker JL; Dominguez-González C; Tasca G; Weiss C; Deconinck N; Fernández-Torrón R; López de Munain A; Camacho-Salas A; Melegh B; Hadzsiev K; Leonardis L; Koritnik B; Garibaldi M; de Leon-Hernández JC; Malfatti E; Fraga-Bau A; Richard I; Illa I; Díaz-Manera J
    Brain; 2020 Sep; 143(9):2696-2708. PubMed ID: 32875335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the sarcoglycan genes in patients with myopathy.
    Duggan DJ; Gorospe JR; Fanin M; Hoffman EP; Angelini C
    N Engl J Med; 1997 Feb; 336(9):618-24. PubMed ID: 9032047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.